CorMedix Inc. (CRMD) financial statements (2022 and earlier)

Company profile

Business Address 300 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments65,46646,35028,33417,62411,98420,16535,386
Cash and cash equivalents53,31741,90516,35017,62410,3808,06411,817
Short-term investments12,1494,44411,984 1,60412,10123,568
Restricted cash and investments132191     
Receivables   116412316
Inventory, net of allowances, customer advances and progress billings3144338429594167377
Inventory3144338429594167377
Prepaid expense526235887944430
Deposits current assets 20     
Other undisclosed current assets8161,416641594539544551
Total current assets:66,46948,18229,34918,66513,26821,83237,059
Noncurrent Assets
Operating lease, right-of-use asset9001,015 
Property, plant and equipment1,4751111271611867038
Deposits noncurrent assets     55
Restricted cash and investments102      
Total noncurrent assets:2,4771,1261271611867543
TOTAL ASSETS:68,94649,30829,47618,82613,45421,90637,102
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,2244,0525,8257,7556,1723,9882,931
Accounts payable2,2101,1281,0242,5891,8081,6451,709
Accrued liabilities3,0142,9244,8005,1664,3642,3421,222
Deferred revenue  2
Other undisclosed current liabilities121109 1188104130
Total current liabilities:5,3454,1625,8277,7666,2614,0923,061
Noncurrent Liabilities
Long-term debt and lease obligation80292436,125   
Long-term debt, excluding current maturities   6,125   
Operating lease, liability8029243
Liabilities, other than long-term debt      29
Deferred revenue and credits  29
Other undisclosed noncurrent liabilities(802)(924)     
Total noncurrent liabilities:80292436,125  29
Total liabilities:6,1485,0855,83013,8926,2614,0923,090
Stockholders' equity
Stockholders' equity attributable to parent, including:62,79844,22323,6464,9347,19317,81534,011
Preferred stock0000000
Common stock383426109714036
Common stock, value, subscriptions  15,200    
Additional paid in capital308,332261,5366183,717159,198136,857128,305
Deferred compensation equity      (0)
Accumulated other comprehensive income871029797988162
Accumulated deficit(245,659)(217,449)(195,421)(178,988)(152,175)(119,165)(94,392)
Other undisclosed stockholders' equity attributable to parent  203,738    
Total stockholders' equity:62,79844,22323,6464,9347,19317,81534,011
TOTAL LIABILITIES AND EQUITY:68,94649,30829,47618,82613,45421,90637,102

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues191239283430329224210
Cost of revenue(149)(205)(373)(397)(115)  
Other undisclosed gross profit     (367)(319)
Gross profit:4234(90)33214(143)(109)
Operating expenses(29,480)(27,255)(20,918)(26,897)(33,138)(24,618)(16,545)
Other operating expense, net
(Other Expenses)
  (2)    
Other undisclosed operating income  2    
Operating loss:(29,438)(27,221)(21,008)(26,864)(32,924)(24,761)(16,654)
Nonoperating income (expense)(23)243023511013029
Investment income, nonoperating  323 12413836
Foreign currency transaction loss, before tax  (21) (14)(8)(7)
Other nonoperating income (expense)(23)24 35   
Interest and debt expense(16)(33)(787)(2)(6)(1)(4)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 33(0)2(190)(11)(1,559)
Loss from continuing operations before equity method investments, income taxes:(29,476)(27,197)(21,494)(26,830)(33,010)(24,644)(18,188)
Other undisclosed income from continuing operations before income taxes16 0    
Loss from continuing operations before income taxes:(29,460)(27,197)(21,494)(26,830)(33,010)(24,644)(18,188)
Income tax benefit1,2505,1695,061    
Net loss:(28,210)(22,028)(16,433)(26,830)(33,010)(24,644)(18,188)
Net loss attributable to noncontrolling interest(28,200)      
Other undisclosed net income attributable to parent28,200   0  
Net loss attributable to parent:(28,210)(22,028)(16,433)(26,830)(33,010)(24,644)(18,188)
Preferred stock dividends and other adjustments      33
Other undisclosed net loss available to common stockholders, basic  (27,103)   (66)
Net loss available to common stockholders, diluted:(28,210)(22,028)(43,536)(26,830)(33,010)(24,644)(18,221)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(28,210)(22,028)(16,433)(26,830)(33,010)(24,644)(18,188)
Other comprehensive income (loss)(15)51(2) 19(37)
Comprehensive loss:(28,225)(22,023)(16,432)(26,832)(33,010)(24,625)(18,224)
Comprehensive loss, net of tax, attributable to noncontrolling interest(28,200)      
Other undisclosed comprehensive income, net of tax, attributable to parent28,200   17  
Comprehensive loss, net of tax, attributable to parent:(28,225)(22,023)(16,432)(26,832)(32,993)(24,625)(18,224)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: